1. An Update on Blood-Brain Barrier Penetrating Nanoparticles for the Treatment of Glioblastoma
Mcgranaghan Ct, Vankeulen-Miller R, Fenton Os, Mcerlean Em
Glioblastoma (GBM) is an aggressive and lethal primary brain malignancy, with patient survival largely unchanged over recent decades despite advances in surgery, radiotherapy and chemotherapy. A major therapeutic challenge is the blood-brain barrier (BBB), which restricts the delivery of many systemically…
- blood-brain barrier
- brain targeting
- brain-targeted nanomedicine
- gene and RNA therapeutics
- glioblastoma
- nanoparticle drug delivery
